These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 31400972

  • 1. Outcomes of Canakinumab Treatment in Recipients of Kidney Transplant With Familial Mediterranean Fever: A Case Series.
    Sendogan DO, Saritas H, Kumru G, Eyupoglu S, Sadioglu RE, Tuzuner A, Sengul S, Keven K.
    Transplant Proc; 2019 Sep; 51(7):2292-2294. PubMed ID: 31400972
    [Abstract] [Full Text] [Related]

  • 2. Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant/unresponsive familial Mediterranean fever.
    Şahin A, Derin ME, Albayrak F, Karakaş B, Karagöz Y.
    Adv Rheumatol; 2020 Jan 30; 60(1):12. PubMed ID: 32000860
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Canakinumab treatment in kidney transplant recipients with AA amyloidosis due to familial Mediterranean fever.
    Trabulus S, Korkmaz M, Kaya E, Seyahi N.
    Clin Transplant; 2018 Aug 30; 32(8):e13345. PubMed ID: 29981275
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis.
    Varan Ö, Kucuk H, Babaoglu H, Guven SC, Ozturk MA, Haznedaroglu S, Goker B, Tufan A.
    Mod Rheumatol; 2019 Mar 30; 29(2):363-366. PubMed ID: 29578360
    [Abstract] [Full Text] [Related]

  • 6. Canakinumab treatment in renal transplant recipients with familial Mediterranean fever.
    Yildirim T, Yilmaz R, Uzerk Kibar M, Erdem Y.
    J Nephrol; 2018 Jun 30; 31(3):453-455. PubMed ID: 29446001
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of anakinra treatment in a patient with colchicine-resistant familial Mediterranean fever.
    Alpay N, Sumnu A, Calışkan Y, Yazıcı H, Türkmen A, Gül A.
    Rheumatol Int; 2012 Oct 30; 32(10):3277-9. PubMed ID: 20386914
    [Abstract] [Full Text] [Related]

  • 8. Anti-IL-1 treatment in familial Mediterranean fever and related amyloidosis.
    Özçakar ZB, Özdel S, Yılmaz S, Kurt-Şükür ED, Ekim M, Yalçınkaya F.
    Clin Rheumatol; 2016 Feb 30; 35(2):441-6. PubMed ID: 25213327
    [Abstract] [Full Text] [Related]

  • 9. Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation.
    Moser C, Pohl G, Haslinger I, Knapp S, Rowczenio D, Russel T, Lachmann HJ, Lang U, Kovarik J.
    Nephrol Dial Transplant; 2009 Feb 30; 24(2):676-8. PubMed ID: 19033248
    [Abstract] [Full Text] [Related]

  • 10. Canakinumab is effective in patients with familial Mediterranean fever resistant and intolerant to the colchicine and/or anakinra treatment.
    Karabulut Y, Gezer HH, Duruöz MT.
    Rheumatol Int; 2022 Jan 30; 42(1):81-86. PubMed ID: 34550430
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of interleukin-1 blockers in kidney transplant recipients with familial Mediterranean fever: a propensity score-matched cohort study.
    Mirioglu S, Dirim AB, Bektas M, Demir E, Tor YB, Ozluk Y, Kilicaslan I, Oto OA, Yalcinkaya Y, Caliskan Y, Artim-Esen B, Yazici H, Inanc M, Turkmen A, Gul A, Sever MS.
    Nephrol Dial Transplant; 2023 May 04; 38(5):1327-1336. PubMed ID: 36542475
    [Abstract] [Full Text] [Related]

  • 13. Anti-interleukin-1 treatment in 26 patients with refractory familial mediterranean fever.
    Kucuksahin O, Yildizgoren MT, Ilgen U, Ates A, Kinikli G, Turgay M, Erten S.
    Mod Rheumatol; 2017 Mar 04; 27(2):350-355. PubMed ID: 27328763
    [Abstract] [Full Text] [Related]

  • 14. Effect of anti-interleukin-1 treatment on quality of life in children with colchicine-resistant familial Mediterranean fever: A single-center experience.
    Kurt T, Aydın F, Nilüfer Tekgöz P, Sezer M, Uncu N, Çelikel Acar B.
    Int J Rheum Dis; 2020 Jul 04; 23(7):977-981. PubMed ID: 32558310
    [Abstract] [Full Text] [Related]

  • 15. Living kidney transplantation between brothers with unrecognized renal amyloidosis as the first manifestation of familial Mediterranean fever: a case report.
    Peces R, Afonso S, Peces C, Nevado J, Selgas R.
    BMC Med Genet; 2017 Aug 31; 18(1):97. PubMed ID: 28859624
    [Abstract] [Full Text] [Related]

  • 16. The Use of Interleukine-1 Inhibitors in Familial Mediterranean Fever Patients: A Narrative Review.
    Hentgen V, Vinit C, Fayand A, Georgin-Lavialle S.
    Front Immunol; 2020 Aug 31; 11():971. PubMed ID: 32670263
    [Abstract] [Full Text] [Related]

  • 17. Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.
    Eroglu FK, Beşbaş N, Topaloglu R, Ozen S.
    Rheumatol Int; 2015 Oct 31; 35(10):1733-7. PubMed ID: 26001859
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of anti-interleukin-1 in children with colchicine-resistant familial Mediterranean fever.
    Erkilet HK, Gezgin Yildirim D, Esmeray P, Söylemezoğlu O.
    Pediatr Int; 2023 Oct 31; 65(1):e15588. PubMed ID: 37658625
    [Abstract] [Full Text] [Related]

  • 19. Renal transplantation in patients with familial Mediterranean fever.
    Erdem E, Karatas A, Kaya C, Dilek M, Yakupoglu YK, Arık N, Akpolat T.
    Clin Rheumatol; 2012 Aug 31; 31(8):1183-6. PubMed ID: 22562368
    [Abstract] [Full Text] [Related]

  • 20. Canakinumab treatment in children with familial Mediterranean fever: report from a single center.
    Yazılıtaş F, Aydoğ Ö, Özlü SG, Çakıcı EK, Güngör T, Eroğlu FK, Gür G, Bülbül M.
    Rheumatol Int; 2018 May 31; 38(5):879-885. PubMed ID: 29450637
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.